Teladoc Health, Inc. Website

Teladoc Health, Inc.

NYSE-TDOC

Basic

  • Market Cap

    $1,541.56M

  • EV

    $2,033.88M

  • Shares Out

    169.59M

  • Revenue

    $2,619.3M

  • Employees

    5,208

Margins

  • Gross

    70.81%

  • EBITDA

    1.76%

  • Operating

    -8.57%

  • Pre-Tax

    -8.79%

  • Net

    -8.9%

  • FCF

    12.81%

Returns (5Yr Avg)

  • ROA

    -31.11%

  • ROTA

    -59.19%

  • ROE

    -40.47%

  • ROCE

    -3.79%

  • ROIC

    -4.49%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $16.21

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $1,097.94M

  • Net Debt

    $492.33M

  • Debt/Equity

    0.69

  • EBIT/Interest

    -9.9

Growth (CAGR)

  • Rev 3Yr

    24.21%

  • Rev 5Yr

    41.8%

  • Rev 10Yr

    62.79%

  • Dil EPS 3Yr

    -38.14%

  • Dil EPS 5Yr

    -1.5%

  • Dil EPS 10Yr

    -16.42%

  • Rev Fwd 2Yr

    2.86%

  • EBITDA Fwd 2Yr

    12.63%

  • EPS Fwd 2Yr

  • EPS LT Growth Est

    20%

Dividends

  • Yield

  • Payout

  • DPS

  • DPS Growth 3Yr

  • DPS Growth 5Yr

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Total Revenues

553.3

1,094

2,032.7

2,406.8

2,602.4

2,619.3

Total Revenues % Chg.

32.4%

97.7%

85.8%

18.4%

8.1%

6%

Cost of Goods Sold, Total

184.5

390.8

650.3

744

760

764.5

Gross Profit

368.8

703.1

1,382.4

1,662.9

1,842.4

1,854.8

Selling General & Admin Expenses, Total

339.1

886.9

1,105.3

1,300.6

1,367.3

1,371.3

R&D Expenses

64.6

164.9

311.9

333.6

348.5

342.9

Depreciation & Amortization

39

69.5

8.9

11.4

11.1

11

Amortization of Goodwill and Intangible Assets

195.3

244.6

325.9

354.1

Other Operating Expenses, Total

442.7

1,121.3

1,621.4

1,890.2

2,052.9

2,079.4

Operating Income

-73.8

-418.2

-239

-227.4

-210.5

-224.5

Interest Expense, Total

-37.9

-60

-81.1

-21.9

-22.3

-22.7

Interest And Investment Income

8.6

0.8

12.7

46.8

51.8

Net Interest Expenses

-29.4

-60

-80.4

-9.3

24.5

29.1

Currency Exchange Gains (Loss)

-0.8

-0.4

Other Non Operating Income (Expenses)

0.3

-0.5

-0.9

4.4

4.4

EBT, Excl. Unusual Items

-102.8

-478.7

-320.2

-237.5

-181.6

-191.3

Restructuring Charges

-7.4

-16.9

-18.5

Merger & Related Restructuring Charges

-6.6

-88.2

-26.6

-15.6

-21.1

-15.5

Impairment of Goodwill

-13,402.8

Gain (Loss) On Sale Of Investments

5.9

Gain (Loss) On Sale Of Assets

-4.9

Asset Writedown

Other Unusual Items

-9.1

-43.7

EBT, Incl. Unusual Items

-109.5

-576

-384.7

-13,663.3

-219.6

-230.3

Income Tax Expense

-10.6

-90.9

44.1

-3.8

0.8

2.8

Earnings From Continuing Operations

-98.9

-485.1

-428.8

-13,659.5

-220.4

-233

Net Income

-98.9

-485.1

-428.8

-13,659.5

-220.4

-233

Preferred Dividend and Other Adjustments

Net Income to Common Incl Extra Items

-98.9

-485.1

-428.8

-13,659.5

-220.4

-233

Net Income to Common Excl. Extra Items

-98.9

-485.1

-428.8

-13,659.5

-220.4

-233

Total Shares Outstanding

72.8

150.3

160.5

162.8

166.7

169.3

Weighted Avg. Shares Outstanding

71.8

90.5

156.9

161.5

164.6

165.8

Weighted Avg. Shares Outstanding Dil

71.8

90.5

156.9

161.5

164.6

165.8

EPS

-1.4

-5.4

-2.7

-84.6

-1.3

-1.4

EPS Diluted

-1.4

-5.4

-2.7

-84.6

-1.3

-1.4

EBITDA

-34.9

-354.5

-31.4

-14.6

46.2

46

Effective Tax Rate

9.7%

15.8%

-11.5%

0%

-0.3%

-1.2%